Clinical trial
The Effects of Cilnidipine on Metabolic Syndrome Improvement
NCT00325936 · Boryung Pharmaceutical Co., Ltd, Industry · Completed
Key facts
| NCT number | NCT00325936 |
|---|---|
| Title | The Effects of Cilnidipine on Metabolic Syndrome Improvement |
| Official title | A Multi-Center, Double-Blind, Randomized, Superiority Clinical Study to Compare the Effects of Cilnidipine on Metabolic Syndrome Improvement With Nifedipine GITS in Hypertensive Patients With Metabolic Syndrome (Phase IV) [SLIMS] |
| Lead sponsor | Boryung Pharmaceutical Co., Ltd, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Metabolic Syndrome X |
| Intervention type | Drug |
| Interventions | Cilnidipine |
| Enrollment | 186 |
| Start date | Jul 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | May 15, 2006 |
| Last update posted | Aug 27, 2008 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: